Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-12-01
1993-01-12
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Lymphokine
424 88, 530350, 530395, 435 693, 435 701, 435 703, 435239, 4352401, 4352403, A61K 3912, C12N 500
Patent
active
051788624
ABSTRACT:
Disclosed is a vaccine for the prevention of disease caused by canine distemper virus (CDV). The vaccine is prepared from CDV immunogens derived from CDV persistently-infected cells cultured in vitro. CCL-64 mink lung cells are the preferred cell line. CDV persistently-infected cells are cultured in serum-containing growth medium, the cells transferred and maintained in serum-free medium under conditions and for a time adequate to accumulate in said serum-free medium said CDV immunogens, and the cells separated from said CDV immunogen-containing supernatant. The CDV vaccine is made by diluting said supernatent and blending with a pharmaceutically-acceptable adjuvant.
REFERENCES:
patent: 3836626 (1974-09-01), Lavender et al.
patent: 4434157 (1984-02-01), Olsen
patent: 4992272 (1991-02-01), Bass et al.
Brown Johnnie R.
Mohamed Abdel A.
Parhelion Corporation
LandOfFree
Canine distemper virus vaccine and method of preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Canine distemper virus vaccine and method of preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine distemper virus vaccine and method of preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1218291